NCT04361409View on ClinicalTrials.gov

Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

January 31, 2017

Conditions
Head and Neck Squamous Carcinoma
Interventions
DRUG

Rituximab

375mg/m2 on Day-14 and Day-7

DRUG

Cisplatin

70mg/m2 on Day1

DRUG

Gemcitabine

1000mg/m2 on Day8

Trial Locations (1)

404

China medical University hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER

NCT04361409 - Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter